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MaThe left atrial appendage (LAA) is a ﬁnger-like extension originating from the main body of the left atrium. Atrial
ﬁbrillation (AF) is the most common clinically important cardiac arrhythmia, occurring in approximately 0.4% to 1% of
the general population and increasing with age to >8% in those >80 years of age. In the presence of AF thrombus,
formation often occurs within the LAA because of reduced contractility and stasis; thus, attention should be given to the
LAA when evaluating and assessing patients with AF to determine the risk for cardioembolic complications. It is clinically
important to understand LAA anatomy and function. It is also critical to choose the optimal imaging techniques to identify
or exclude LAA thrombi in the setting of AF, before cardioversion, and with current and emerging transcatheter therapies,
which include mitral balloon valvuloplasty, pulmonary vein isolation, MitraClip (Abbott Laboratories, Abbott Park,
Illinois) valve repair, and the implantation of LAA occlusion and exclusion devices. In this review, we present the current
data regarding LAA anatomy, LAA function, and LAA imaging using the currently available noninvasive imaging
modalities. (J Am Coll Cardiol Img 2014;7:1251–65) © 2014 by the American College of Cardiology Foundation.A trial ﬁbrillation (AF) occurs in approximately0.4% to 1% of the general population,increasing with age to >8% in those >80
years of age, with prevalence projected to more than
double by 2035 (1–3). In 1909, Welch (4) noted that car-
diovascular stroke associated with AF was due to left
atrial appendage (LAA) thrombi and that this was the
most common site for thrombus formation in the
setting of AF (5). Meticulous attention should be given
to the LAA when evaluating patients with AF to deter-
mine the risk for cardioembolic complications, espe-
cially before proceeding with cardioversion. In
addition, the development of new interventional
transcatheter procedures for AF, mitral valve repair,
atrial septal defect closure, and LAA occlusion may
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LAA ANATOMY
The LAA derives from the primordial left atrium (LA),
which is formed mainly by the adsorption of the pri-
mordial pulmonary veins and their branches (6). It is
a ﬁnger-like projection from the main body of the LA.
The junction is fairly well deﬁned by a narrowing at
the oriﬁce of the appendage. There are considerable
variations in its size, shape, and relationship with
adjacent cardiac and extracardiac structures, which
can be extremely relevant when interventional pro-
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ABBR EV I A T I ON S
AND ACRONYMS
AF = atrial ﬁbrillation
CMR = cardiac magnetic
resonance
ICE = intracardiac
echocardiography
LA = left atrium
LAA = left atrial appendage
LV = left ventricular
MDCT = multidetector
computed tomography
SEC = spontaneous
echocardiographic contrast
SR = sinus rhythm
TEE = transesophageal
echocardiography
2D = 2-dimensional
3D = 3-dimensional
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1252In most hearts, the LAA extends between
the anterior and the lateral walls of the LA, and
its tip is directed anterosuperiorly, over-
lapping the left border of the right ventricular
outﬂow tract or the pulmonary trunk and the
main stem of the left coronary or the circum-
ﬂex artery. It is not uncommon to ﬁnd the tip
of the LAA directed laterally and backward.
However, in a small percent of hearts, the tip
of the LAApasses behind the arterial pedicle to
sit in the transverse pericardial sinus. The
external appearance of the LAA is that of a
slightly ﬂattened tubular structure with
crenellations, often with one or more bends
and terminating in a pointed tip. Because of its
slightly ﬂattened shape, the lower surface
usually overlies the left ventricle and the
upper surface is beneath the ﬁbrous pericar-
dium. Internally (Figure 1A), the oriﬁce of the
appendage is usually oval, whereas round,triangular, and water-drop shapes are observed less
frequently (7,8). The left lateral ridge separates the
oriﬁces of the left pulmonary veins from the LAA
oriﬁce, but the precise relationship between the level
of the oriﬁce and its distance to the venous oriﬁces
varies (9). The smooth muscular wall of the LA vesti-
bule separates the oriﬁce from the mitral annulus.
Most appendages have a well-deﬁned oriﬁce that
leads to a neck region that opens to the body of the
appendage. In a large study of postmortem hearts,
Veinot et al. (10) deﬁned lobes as protrusions from the
main body with the tail portion also representing a
lobe, whereas bends in the tail do not constitute more
lobes. They found that 2 lobes were most common
(54%), followed by 3 lobes (23%), 1 lobe (20%), and
4 lobes (3%), and noted there were no signiﬁcantE 1 Oriﬁce of the LAA and the Pectinate Muscles Within It
e LAA imaged from within the LA in an explanted heart showing
ponding computed tomography 3D reconstruction from within th
; LAA ¼ left atrial appendage; TEE ¼ transesophageal echocardioage- or sex-related differences in LAA morphologies.
An increased number of lobes was associated with the
presence of a thrombus independent of clinical risk
and blood stasis (11). In a recent study using multi-
detector computed tomography (MDCT) and cardiac
magnetic resonance (CMR), the shapes of the LAA in
patients with drug-refractory AF were classiﬁed into
4 morphological types (Figures 2 and 3), with “chicken
wing” being the most common (48%), followed by
“cactus” (30%), “windsock” (19%), and “cauliﬂower”
(3%) (12). The “cauliﬂower” morphology is most often
associated with an embolic event. It is described as
having a short overall length, more complex internal
characteristics, a variable number of lobes with lack
of a dominant lobe, and a more irregular shape of
the oriﬁce. The “cactus shape” has a dominant
central lobe and secondary lobes arise from it su-
periorly and inferiorly, whereas the “windsock” has
a dominant lobe as the primary structure and there
are variations in the location and number of sec-
ondary or even tertiary lobes. The “chicken wing”
has a dominant lobe that presents with an obvious
bend in its proximal or middle part, folding back on
itself at some distance from the oriﬁce, and it may
have secondary lobes. Figure 4 demonstrates endo-
casts emphasizing that there can be overlap between
the different morphologies when viewed from
different angles. As elegantly demonstrated by Stöll-
berger et al. (13), the shape, lobes, and branches
depend on the imaging plane.
Casts of the inner surface of the LAA reveal complex
indentations made by the pectinate muscles that line
the cavity of the appendage. Themuscle bundles in the
LAA do not ramify like the teeth of a comb. Instead,
they have a feather-type-palm-leaf arrangement,
especially at the borders between superior and inferiortransilluminated thin walls between the pectinate muscles. (B)
e LA. (C) 2D TEE; arrows point to the pectinate muscles. LA ¼ left
graphy; 2D ¼ 2-dimensional; 3D ¼ 3-dimensional.
FIGURE 2 Anatomic Variants of LAA Morphology
Sample images taken from explanted hearts demonstrating different LAA morphologies (top). (A) Chicken wing. (B)Windsock. (C) Cauliﬂower.
(D) Cactus. Abbreviation as in Figure 1.
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1253surfaces; are strap-like; or resemble a fan-type-palm-
leaf arrangement near the border with the atrial ves-
tibule (14). As shown in Figure 5A, the thicker muscle
bundles may be mistaken for thrombi or intra-atrial
masses (10). The remainder of the LAA wall in
between the muscle bundles is paper-thin (Figure 1A).
Studies of heart specimens and casts from patients
in sinus rhythm (SR) compared with those from pa-
tients with AF revealed structural remodeling of the
LAA with dilation of the chamber and a reduction in
the number of pectinate muscles (15,16).
LAA FUNCTION AND THROMBUS FORMATION
Normal contraction of the LAA during SR, as demon-
strated in Figure 6, and adequate blood ﬂow within
the LAA lower the risk for formation of thrombi inside
its cavity. Thrombus formation is more likely to occur
within the LAA when reduced contractility and stasis
ensue. As shown in Figure 7, during AF there is adecrease in LAA contractility and function, manifest
as a decrease in Doppler velocities and dilation of the
LAA (17,18). The remodeling process associated with
AF causes the LAA to function as a static pouch, pre-
disposing to stagnation and thrombosis. Limited data
suggest that patients with signiﬁcant left ventricular
(LV) dysfunction and elevated LV end-diastolic pres-
sures also may be at risk for an LAA thrombus for-
mation in the absence of AF. Vigna et al. (19) found
LAA thrombi in 8 of 58 patients with dilated cardio-
myopathy who were in SR. Consequently, the risk of
thrombus formation in the LAA seems to be related to
impaired LAA function, reduced contractile function,
and elevated ﬁlling pressures regardless of its cause.
LAA thrombi are present in up to 14% of patients with
acute (<3 days) AF (20). Moreover, thrombus forma-
tion may develop even in patients with AF who are
receiving therapeutic anticoagulation therapy. A
transesophageal echocardiography (TEE) study found
that 1.6% of patients treated with anticoagulation for 1
FIGURE 3 LAA: Morphologies and Modalities
The 4 different LAA morphologies as shown by TEE (top), cine angiography (middle), and 3D computed tomography (bottom). Cauliﬂower (A to C), windsock (D to F),
cactus (G to I), and chicken wing (J to L). Abbreviations as in Figure 1.
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1254month had echocardiographic evidence of an LAA
thrombus (21). These ﬁndings underscore the signiﬁ-
cant and important role of noninvasive imaging for
detection of LAA thrombi.
In animal studies, removal of the LAA was found to
decrease compliance of the LA, which was associated
with signiﬁcant changes in LV and LA ﬁlling and atrial
function. Whether these effects of LAA removal are
due to changes in LA geometry or to loss of a region
with different distensibility is currently unknown, as
well as the clinical implications (22).
NONINVASIVE IMAGING OF THE LAA
FOR RISK ASSESSMENT
ECHOCARDIOGRAPHY. Although initial studies us-
ing transthoracic echocardiography demonstrated itto have limited ability for detection of LA and LAA
thrombus formation (23,24), the use of harmonic im-
aging and administration of ultrasound contrast
agents have enhanced the capability of transthoracic
echocardiography to detect LAA thrombi (25,26).
TEE has made accurate assessment and imaging of
the LAA possible, allowing the evaluation of LAA
morphology and ﬂow patterns within it. TEE is
currently the most widely used and accepted modality
to diagnose and exclude the presence of LAA thrombi.
The sensitivity and speciﬁcity of TEE for detection of
LAA thrombi when compared with intraoperative ob-
servations are 92% and 98%, respectively (27,28), with
negative and positive predictive values of 100% and
86%, respectively (28). A complete TEE evaluation of
the LAA should include imaging of the accompanying
structures, such as the LA, LV, and mitral valve, along
FIGURE 4 Endocasts Obtained From 2 Explanted Hearts Showing the Different LAA Intraluminal Morphologies
(A) Chicken wing. (B) Windsock. (C) Cauliﬂower. (D) Cactus. A, B and C, D are pairs of the same casts but viewed from different perspectives
showing the overlap that exists regarding LAA morphology. Abbreviation as in Figure 1.
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1255with a detailed assessment of LAA morphology,
contraction, and ﬂow velocities using 2-dimensional
(2D) and 3-dimensional (3D) echocardiography.
Exclusion of LAA thrombi using TEE can also allow
early, and safe, cardioversion avoiding the need for
prolonged anticoagulation therapy prior to cardio-
version (29). The different aspects used for echocar-
diographic evaluation of LAA anatomy, function, and
ﬂow are further detailed in Table 1.
2D AND 3D ECHOCARDIOGRAPHY. As shown in
Figure 8, TEE imaging of the LAA is best obtained using
a multiplane approach in both the long-axis and the
short-axis views, as well as with the use of 3D imaging.
In cases in which LAA images are suboptimal, ultra-
sound contrast agents are useful to enhance visuali-
zation of the LAA. The use of contrast eliminates many
of the artifacts and generally demonstrates complete
opaciﬁcation of the LAA or reveals ﬁlling defects in its
body (30,31). Although patients with dense sponta-
neous echocardiographic contrast (SEC) seen within
the LAA have a stroke rate of 18.2% per year if un-
treated with warfarin and a 4.5% per year stroke risk
with adjusted-dose warfarin, the presence of an LAA
thrombus triples the overall rate of stroke (32).
Table 2 and Figure 5 list and demonstrate the
different ﬁndings that can be encountered duringechocardiographic evaluation of the LAA. Because of
the complex anatomic features of thrombi, they can
be difﬁcult to detect and thus missed. Conversely,
overdiagnosis of thrombi can result from misinter-
pretation of acoustic shadowing from the ligament of
Marshall or misinterpretation of pectinate muscles as
thrombi (Figures 5A and 5B). Whether the presence of
sludge or dense SEC within the LAA should be
regarded equivalently as the presence of a thrombus
is controversial (33).
Imaging with 3D TEE is a relatively recent devel-
opment that improves assessment of LAA anatomy.
Although 2D TEE provides higher-resolution images
because of a better frame rate, 3D TEE allows a more
comprehensive assessment of the LAA by overcoming
some of the limitations associated with 2D imaging,
such as inadequate imaging planes. In addition, 3D
TEE provides better separation and differentiation
between adjacent structures, along with a more
complete and comprehensive evaluation of the LAA,
its complex morphology, and the surrounding struc-
tures (25,34,35). Data are still limited regarding the
sensitivity and speciﬁcity of 3D TEE for detecting LAA
thrombi. However, with recent advances in percuta-
neous device therapy for LAA closure, 3D TEE has
become important to guide device delivery into the
FIGURE 5 Abnormal TEE Findings Within the LAA
(A) The presence of a large pectinate muscle can sometimes be confused for an LAA thrombus. (B) In this case, the pectinate muscle is better deﬁned by 3D TEE. (C) SEC
is seen in the LAA. (D) A more echo-dense, amorphous ﬁnding consistent with sludge is seen within the LAA (arrowheads). Zero-degree (E) and 95 (F) views and 3D
imaging (G) show a thrombus within the LAA (arrows). SEC ¼ spontaneous echocardiographic contrast; other abbreviations as in Figure 1.
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1256LAA. Table 3 details the potential advantages of 3D
echocardiography compared with 2D echocardiogra-
phy for LAA and LA evaluation (18,35–43).
Intracardiac echocardiography (ICE) can provide an
alternative imaging method when TEE is not obtain-
able. ICE can provide multiple views and detailed
imaging of the LAA (44) to reliably diagnose the
presence of thrombi (45). Although ICE is less sensi-
tive compared with TEE for thrombus detection (46),
it can serve as a complementary method, especially
when equivocal TEE ﬁndings merit further evalua-
tion. However, because ICE is an invasive procedure,
its use is limited in daily practice and is mainly
reserved for the catheterization laboratory during
planned interventional cardiac procedures.
DOPPLER. Because the LAA is generally multilobed,
it can be difﬁcult to visualize in its entirety, even with
3D imaging. In addition, TEE has limited sensitivity
for identiﬁcation of small thrombi or thrombi within a
side lobe. Thus, the absence of visualizing an LAAthrombus does not equate with the absence of an LAA
thrombus. To better assess the LAA and the risk of
thromboembolism, functional assessment of the LAA
using Doppler echocardiography is routinely used
(47). Evaluation of LAA Doppler velocities is requisite
to help exclude LAA thrombi. In SR, the LAA is usu-
ally a highly contractile muscular sac that obliterates
its apex during atrial systole. This can be seen by TEE
and conﬁrmed by pulsed and color ﬂow Doppler. The
LAA velocity and color ﬂow in SR are concordant with
LAA reduction in size, reﬂecting true contraction,
whereas in AF this normal pattern is usually replaced
by a chaotic one of varying velocities (Figure 9). Flow
in the appendage should be assessed after optimally
aligning the pulsed-wave Doppler signal with the
LAA ﬂow using color ﬂow imaging, with the sampling
done at the site where maximal ﬂow velocities are
obtained (usually in the proximal third of the
appendage) (47). In normal subjects, without known
cardiac abnormalities, LAA contraction is biphasic
FIGURE 6 Change in Size of the LAA During the Cardiac Cycle in a Patient in SR
In this patient in SR, the LAA (arrowhead) can be seen in varying sizes during the different phases (A to F) of the cardiac cycle (yellow arrow
pointing to time frame of cycle). SR ¼ sinus rhythm; other abbreviation as in Figure 1.
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1257with velocities ranging from 50  6 cm/s to 83  25
cm/s with ﬁlling velocities ranging from 46  12 cm/s
to 60  19 cm/s (48–52). Decreased velocities in pa-
tients in SR can be observed in the presence of
elevated LA pressure (51). In patients with AF, ﬂow
signals from the LAA are highly variable with a
sawtooth pattern or the absence of identiﬁable
ﬂow waves (48,53), although they tend to have lower
velocities during ventricular systole (when the
LAA contracts against a closed mitral valve) with
increasing heart rate reducing the peak ﬂow velocity
(54). Velocities were found to be highest in subjects in
SR, intermediate in subjects with paroxysmal AF and
atrial ﬂutter, and lowest in subjects with chronic AF
(55–58). Velocities <40 cm/s are associated with a
higher risk of stroke and the presence of SEC (59),
with decreasing velocities of <20 cm/s associated
with the identiﬁcation of thrombus within the LAA
and a higher incidence of thromboembolic events
(32,48,50,55,60). The presence of velocities <40 cm/s
requires meticulous evaluation of the LAA before
cardioversion or device intervention involving the LAand LAA. In addition, as shown in Figure 10, setting
the color Doppler to a low Nyquist limit can aid in
visualizing ﬂow and help detect or exclude the pres-
ence of a thrombus. Absence of color ﬂow in the
LAA’s distal tip or side lobes may indicate the absence
of ﬂow because of the lack of ﬁlling from a thrombus.
Although a decrease in LAA function has been
demonstrated in patients with AF, atrial ﬂutter, or SR
(50,53,55,61), its signiﬁcance has been widely evalu-
ated only in the setting of AF. In patients in SR, the
presence of SEC has a greater association with stroke
risk than reduced LAA emptying velocities (62). The
role of LAA dysfunction for predicting embolic events
in patients in SR has not been widely addressed.
When Doppler signals are suboptimal, the use of a
microbubble contrast agent enhances detection of
LAA Doppler ﬂow velocities (63). A useful algorithm
detailing the approach for the evaluation of the LAA
is shown in Figure 11.
ADDITIONAL PARAMETERS. Doukky et al. (64) found
that E/e’ and e’ velocities are independently associ-
ated with an LAA thrombus in patients with
TABLE 1 Different Echocardiography Modalities Evaluated When Usin
Echocardiographic Modality Parameters Evaluated
2D and 3D echocardiography Visual assessment for the presence o
other pathologies within the LAA
Table 2.
Spectral Doppler Evaluation of ﬂow in the LAA using p
Doppler:
Velocities >40 cm/s are suggestive o
ﬂow within the appendage and a
thrombus formation.
Color Doppler to a low Nyquist limit
visualization of ﬂow within the L
Tissue Doppler and strain imaging Limited studies.
E/e’ and e’ velocity were found to be
associated with an LAA thrombus
with nonvalvular AF.
Compromised LAA contractile fraction
speckle-tracking, strain-based me
independent determinant of LAA
AF ¼ atrial ﬁbrillation; ICE ¼ intracardiac echocardiography; LAA ¼ left atrial appendag
FIGURE 7 Diameter and Area Changes of the LAA Oriﬁce During the Cardiac Cycle
(Top) A patient in normal SR who had LAA contractility. Systole (A) and diastole (B).
(Bottom) A patient with long-lasting AF. Systole (C) and diastole (D). Note the difference
in area between systole and diastole in the patients in SR opposed to the minimal change in
the area in the patient in AF where there is considerably reduced contractility. In this
patient in AF, the LAA oriﬁce is markedly enlarged; note that a 32-mm Carpentier ring in
the mitral position (bottom right in C and D, red arrow) is visually smaller in diameter than
the LAA oriﬁce (yellow arrow). AF is associated with structural remodeling of the LAA,
which includes dilation of the chamber and reduction in pectinate muscles (not shown).
AF ¼ atrial ﬁbrillation; SR ¼ sinus rhythm; other abbreviation as in Figure 1.
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1258nonvalvular AF, supporting the physiologic plausi-
bility that LV diastolic dysfunction and LA elevated
ﬁlling pressure also may contribute to stasis leading
to LAA thrombus formation in patients with AF.
A limited number of studies evaluated the use
of tissue Doppler imaging for evaluation of the
LAA before cardioversion. Patients with an LAA
thrombus demonstrated the lowest LAA contraction
velocities (65); thus, tissue Doppler imaging can be
complementary to ﬂow velocities when evaluating
the LAA (66,67). Compromised LAA contractile
fraction, measured by speckle tracking (strain-based
methods), seems to be an independent determinant
of LAA thrombus (68). A reduced strain rate was
found to correlate with LAA emptying velocities af-
ter cardioversion (69). At present, these methods
have not been extensively validated or routinely
adopted.
LAA FUNCTION AND TEE ASSESSMENT POST-
CARDIOVERSION. Post-cardioversion temporary
stunning, paradoxical reduction in LAA ﬂow veloc-
ities, and worsening mechanical function of both
the LA (70–72) and the LAA (72–78) can appear, pre-
disposing to the appearance of SEC and thrombus
formation, highlighting the need for adequate anti-
coagulation therapy before and after cardioversion.
LAA stunning post-cardioversion occurs whether
conversion to SR is spontaneous (73) or associated
with direct current cardioversion, either external
(71,74,77,79) or low-dose internal (75), or pharmaco-
logical cardioversion (74,79). Despite there being
higher ﬂow velocities in the LAA in most patients withg Echocardiography to Assess the LAA
Comments
f thrombi or
as noted in
If there is inadequate visualization or artifacts,
ultrasound contrast agents can enhance
visualization.
ICE can serve as a complementary method for
evaluation.
ulsed-wave
f adequate
low risk for
can aid in
AA.
Easily performed, highly reproducible, and carries
relevant clinical implications.
When Doppler signal is limited, microbubble contrast
agent enhances visualization of contractility
indices.
independently
in patients
, measured by
thods, was an
thrombus.
Not routinely used.
e; 2D ¼ 2-dimensional; 3D ¼ 3-dimensional.
FIGURE 8 TEE Imaging of the LAA
TEE images in (A, B) 2D X-plane view demonstrating a ﬁnding suspicious of a thrombus (arrow). (C)With the use of contrast, a thrombus is now
clearly demonstrated, as well as in the 3D view (D) (Online Videos 1, 2, and 3). Abbreviations as in Figure 1.
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1259atrial ﬂutter, stunning also occurs after conversion of
atrial ﬂutter to SR (78). Stunning usually resolves
within several days after cardioversion to SR (72). The
total energy used for electrical cardioversion has no
effect on themechanical function of the LA or LAA (76).
These ﬁndings support the concept that mechanisms
other than the electrical shock itself are responsible for
stunning. As shown in Figure 9, the occurrence of
stunning post-cardioversion (deﬁned as LAA peak late
diastolic emptying velocities <20 cm/s) (80) is not
uniform. High LAA ﬂow velocities post-cardioversionTABLE 2 Transesophageal Echocardiographic Evaluation of the LAA
Pathophysiology Echocardiog
SEC Low blood ﬂow velocities.
Composed of activated platelets and
leukocytes or aggregated red blood
cells.
Swirling echo
atrium.
Sludge Low blood ﬂow velocities. Viscous, gela
not well f
an interm
SEC and f
Thrombus Low blood ﬂow velocities. Organized fo
Pectinate muscle Part of the normal LAA morphology.
LAA ¼ left atrial appendage; SEC ¼ spontaneous echocardiographic contrast.can identify patients with a greater likelihood of
maintaining normal SR at 1 year post-cardioversion
(81). However, the presence of low LAA ﬂow veloc-
ities after cardioversion are of limited value in identi-
fying those who will develop a recurrence of AF within
1 year (81).
ADDITIONAL NONINVASIVE IMAGING MODALITIES.
Although TEE is the most widely used method for
evaluation of the LAA, MDCT and CMR are emerging
as valuable modalities for imaging and assessment ofraphic Appearance Treatment Figure
density within the Anticoagulation does not reduce SEC but
reduces the development of LAA
thrombus.
Cardioversion is acceptable. SEC can
initially increase, but eventually
decreases after cardioversion.
5C
tinous morphology,
ormed. Represents
ediate stage between
ormed thrombus.
Anticoagulation. Cardioversion in the
setting of sludge is controversial and
associated with a higher risk of
thrombus being present.
5D
rmed thrombus. Anticoagulation. Cardioversion
contraindicated with this ﬁnding.
5E, F
No treatments, normal ﬁnding. 5A, B
TABLE 3 Potential Advantages of 3D Echocardiography Compared With
2D Echocardiography for LAA Evaluation
3D TEE can be helpful in differentiating a thrombus from other ﬁndings, such as pectinate
muscles within the LAA (35).
3D echocardiography is superior to 2D echocardiography for assessment of thrombus mobility
and differentiation between the thrombus and the myocardium (36).
3D echocardiography is superior to 2D echocardiography for delineation of the changes in
thrombi structure (e.g., calciﬁcation, degeneration, or lysis) (36).
3D echocardiography measurements of maximum thrombus diameter showed better
interobserver agreement than 2D echocardiography (36).
LAA volume calculation and volume-derived ejection fraction can be obtained by 3D
echocardiography only (36,42).
3D TEE renders additional information compared with 2D TEE regarding type and site of
intracardiac masses, surface features, and spatial relationship to surrounding structures (37).
3D echocardiography (transthoracic echocardiography [TTE]/TEE) is superior to 2D
echocardiography (TTE/TEE) in the adequate visualization of the entire LAA (38).
The LAA oriﬁce area is measured more precisely by 3D TEE using enface views; 3D measurements
correlated well with MDCT values, whereas 2D TEE underestimates the LAA oriﬁce area
(18,39).
2D TTE/TEE probably underestimates the dimensions of intracardiac masses, compared with 3D
TTE/TEE, regardless of the size, location, and cause of the mass (37,40).
An excellent correlation on volume measurement between 3D TEE and surgically removed
masses has been demonstrated (41).
3D TEE is superior to 2D TEE in visualizing the LAA oriﬁce in relation to surrounding structures
(e.g., mitral valve, left upper pulmonary vein) (43).
LAA ¼ left atrial appendage; MDCT ¼ multidetector computed tomography; TEE ¼ transesophageal
echocardiography; TTE ¼ transthoracic echocardiography; 2D ¼ 2-dimensional; 3D ¼ 3-dimensional.
FIGURE 9 LAA Velocities Pre- and Post-Cardioversion
(Top) In this patient in AF, pre-cardioversion LAA velocities (left) are ap
increased to 80 cm/s. (Bottom) Pre-cardioversion, LAA velocities (left)
<20 cm/s post-cardioversion while the patient is in SR (right), reﬂectin
abbreviation as in Figure 1.
FIGURE 10 Lowering of the Nyquist to Aid in
Thrombus Detection
In this patient, there was a suspicion for a thrombus in the LAA
(arrow). By using color Doppler and reduction of the Nyquist
limit to 15 cm/s, a color ﬂow ﬁlling defect supporting the
diagnosis of an LAA thrombus is observed (Online Video 4).
Abbreviation as in Figure 1.
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1260the LAA anatomy and function. Table 4 summarizes
the main strengths and limitations of each of the
noninvasive imaging modalities. MDCT and CMR
are likely to have an increasing role in the pre- andproximately 35 cm/s. Post-cardioversion (right), in SR, LAA velocities
were approximately 50 cm/s with LAA velocities decreasing to
g LAA stunning. AF ¼ atrial ﬁbrillation; SR ¼ sinus rhythm; other
Consider Administration of Echo
Contrast for Further Evaluation
TEE Performed for Evaluation Prior to
Cardioversion
LAA Thrombus
Present
Safe to Perform
Cardioversion*
Findings Suspicious for
the Presence of Thrombi
Do Not Proceed with
Cardioversion
Doppler Evaluation of
LAA Velocities: > 40 cm/s
No
No
No Yes
Yes
Yes
FIGURE 11 Schematic Approach for TEE Evaluation of the LAA Before Cardioversion
*Safe if no other contraindications exist for the patient. TEE refers to 2D TEE, but 3D TEE should be used, if available, to increase sensitivity
and speciﬁcity of ﬁndings. Abbreviations as in Figure 1.
TABLE 4 Comparison of the Different Imaging Modalities for Assessment of the LAA
TEE MDCT CMR
Sensitivity/speciﬁcity
for LAA thrombi
detection
92%–100%/
98%–99%
96%/92% 67%/44%
Spatial resolution 0.2–0.5 mm 0.4 mm 1–2 mm
Temporal resolution 20–33 ms 70–105 ms 30–50 ms
3D volume rendering Yes (with 3D) Yes Yes
Contrast required No* Yes No*
Ionizing radiation No Yes No
Special considerations Widely available,
provides
real-time
assessment
Semi-invasive
Noninvasive, dynamic
assessment of LA
function
Cannot be performed
real-time during
procedures
Limited availability
Noninvasive, cannot
be performed
real-time during
procedures
Limited availability
Cannot be performed
in patients
with pacemakers
*Contrast may be used to enhance visualization of a thrombus in equivocal cases.
CMR ¼ cardiac magnetic resonance; LA ¼ left atrium; other abbreviations as in Table 3.
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1261post-procedural evaluation of the LAA when their
imaging resolution improves to allow for accurate
determination and exclusion of thrombus.
MDCT. MDCT generates 3D volumetric data of the
entire heart, which can be reconstructed along
different planes and cardiac phases to provide accurate
assessment of LAA anatomy (Figure 3). Current ad-
vances in MDCT now permit high spatial and temporal
resolution, 3D imaging, and quantitative assessment
to permit successful identiﬁcation of LAA thrombi and
nondense clearing SEC as seen by TEE (82–85). In the
largest series to date of 402 patients, MDCT had a
negative predictive value and a sensitivity of 100% for
excluding LAA thrombi when compared with TEE (86).
The reported positive predictive value of MDCT ranges
from 41% to 92% depending on the method used for
acquisition of data (87). A positive MDCT scan is not
highly speciﬁc for the presence of a thrombus, and thus
the high rate of false-positive test results and poor
interobserver variability (88) are major limitations for
accurate detection of thrombi by MDCT. The sensi-
tivity and speciﬁcity, and the positive and negative
predictive value can be enhanced when delayed im-
aging, a method used to differentiate between poor
LAA ﬁlling and SEC or thrombus, is used (87). Limita-
tions of MDCT include the following: 1) LAA mechani-
cal function is not routinely evaluated, unless
retrospective gating is used to assess dynamicfunction; however, this method is associated with
signiﬁcantly higher radiation doses (89); 2) radiation
and the use of iodine-based contrast media; and
3) signiﬁcantly lower temporal resolution than TEE.
CMR. CMR is an alternative, noninvasive imaging
modality for those cases in which TEE is not possible,
namely, in patients with esophageal pathology and
unsuccessful TEE probe insertion. However, this
TABLE 5 Comparison Between MDCT and TEE for Evaluation
of the LAA Including Assessment of Patients for Percutaneous
LAA Closure
MDCT TEE
LAA thrombus detection þ 2D/3D þþ
Assessment of LAA function þ þþþ
LAA oriﬁce size þþ 2D þ 3D þþ
LAA morphology þþ 2D þ 3D þþ
Evaluation of intracardiac structures þþþ 2D þ 3D þþþ
Evaluation of extracardiac structures þþþ -
Intraprocedural guidance - 2D þþ 3D þþþ
Abbreviations as in Table 3.
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1262modality has been evaluated in a limited number of
studies. CMR accurately visualizes LAA size and
function, and has the potential to detect thrombus in
patients with AF (90). In a CMR study, patients with a
history of stroke had larger LAA mean volumes than
control subjects (28.8  13.5 cm3 vs. 21.7  8.27 cm3,
p ¼ 0.002), with the highest risk found in patients
with an LAA volume >34 cm3 (multivariable odds
ratio: 7.11, p ¼ 0.003) (90). The sensitivity and spec-
iﬁcity of CMR to identify the presence of possible
LAA thrombus are similar to those of MDCT. Ohyama
et al. (91) evaluated CMR and TEE for the detection
of LAA thrombi and found a high concordance be-
tween the modalities, with all 16 patients with
thrombus being correctly identiﬁed; however, there
were 3 false-positive CMR cases (negative predictive
value: 100%, positive predictive value: 84%). In a
study by Rathi et al. (92), 97 patients with AF un-
derwent TEE and CMR. They found 100% concor-
dance between these modalities for detection of
LAA thrombi. Akoum et al. (93) evaluated the use
of late gadolinium enhancement to quantify atrial
ﬁbrosis. They demonstrated that atrial ﬁbrosis on
CMR was independently associated with LAA thrombi
and spontaneous contrast. This might provide an
additional risk stratiﬁcation method beyond clinical
parameters (93).
CMR can measure blood ﬂow using velocity-
encoded techniques. A small study (N ¼ 30) com-
paring CMR velocity-encoded technique to assess
LAA emptying velocities was compared with TEE
(94). A good correlation was found between CMR and
TEE emptying measurements (r ¼ 0.61, p < 0.0001).
However, there was a mean underestimation of 10 
15 cm/s for peak A-wave velocities by velocity-
encoded CMR compared with TEE. Although CMR
has several advantages compared with MDCT and
TEE, such as lack of exposure to iodine contrast and
radiation, as well as not necessitating the passage of a
probe, there are still several limitations that limit its
widespread use, such as lower spatial resolution,
prolonged examination duration, dependence on
breath holds, and inability to be performed in pa-
tients with implanted cardiac devices.
DEVICE THERAPY FOR LAA EXCLUSION
LAA device closure is an evolving treatment strategy
to prevent embolic events in patients with non-
valvular AF (95). There are currently 2 strategies
available for percutaneous LAA closure: LAA occlu-
sion and LAA exclusion. Occlusion refers to the
placement of an intravascular device into the LAA
percutaneously, through a venous access, andexclusion refers to exclusion of LAA from circulation
by applying an external ligature. The 2 most
commonly used devices for LAA occlusion are the
Watchman Device (Boston Scientiﬁc Corp., Natick,
Massachusetts) and the Amplatzer Cardiac Plug
(St. Jude Medical, Inc., St. Paul, Minnesota). Cur-
rently, there is only one device for LAA exclusion:
the LARIAT snare device (SentreHEART Inc.,
Redwood City, California), which uses a ligation su-
ture for exclusion of the LAA. Noninvasive imaging
modalities, including 2D and 3D TEE, and MDCT
aid in the assessment of the LAA anatomy, the oriﬁce,
and the “landing zone” diameters for determining
suitability for device implantation. 3D TEE has been
shown to correlate better than 2D TEE for assessment
of LAA oriﬁce size when compared with MDCT (18),
which has been shown to accurately assess both
anatomy and oriﬁce sizing, making it a useful tool
during the pre-procedural planning period in select
populations. MDCT provides valuable information
about the shape of the LAA and for deﬁning its re-
lationships with surrounding critical structures, such
as the left upper pulmonary vein and the left
circumﬂex artery (7). Table 5 compares MDCT and TEE
and highlights the strengths of each modality. Newer
imaging modalities incorporating fusion/integrated
imaging would increase the conﬁdence and anatomic
awareness, assist in guidance, and increase proce-
dural efﬁciency (96).
CONCLUSIONS
The LAA, the most common site for thrombus for-
mation in the setting of chronic or paroxysmal AF,
is a complex structure. Multiplane 2D and 3D TEE
with spectral and color Doppler, as well as echo-
cardiographic contrast agents, are useful to identify
and exclude LAA thrombi. The nonuniform anatomy
of the LAA requires a multiparameter approach
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 1 2 , 2 0 1 4 Beigel et al.
D E C E M B E R 2 0 1 4 : 1 2 5 1 – 6 5 LAA Anatomy and Imaging
1263for the evaluation and detection of thrombi, and
for the adequate assessment before novel device
therapy, which is rapidly evolving. New trans-
catheter techniques make it a requisite to identify
the presence of LAA thrombi to prevent systemic
thromboembolism.REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Robert J. Siegel, Cedars Sinai Medical Center, 127
South San Vicente Boulevard, Suite A3600, Los
Angeles, California 90048. E-mail: Robert.siegel@
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